Skip to content
Independent analysis of NHS open data
PharmaInsight

Natalizumab

Malignant Disease and Immunosuppression Drugs affecting the immune response BNF 0802040W0
Data updated October 2024 Download CSV
1items

Dispensed in October 2024

0items

Rolling 12 months

£1,130

Net ingredient cost · October 2024

Figure 1. Natalizumab: national items dispensed by month

0 1 2 Jul 2023 Aug 2023 Nov 2023 Jun 2024 Oct 2024 1 Jul 2023: 2 Aug 2023: 1 Nov 2023: 1 Jun 2024: 1 Oct 2024: 1

Source: NHSBSA Prescription Cost Analysis, to October 2024

Download CSV
Embed this chart

At a glance

  • Therapeutic class Drugs affecting the immune response
  • Presentations 1 shown
  • Average cost / item £1,130.00
What this is
Net ingredient cost is the list price before discounts and dispensing fees, not what the NHS finally pays.

Top presentations, October 2024

The individual products dispensed under Natalizumab this month.

Presentations of Natalizumab, October 2024
Presentation BNF code Items Net ingredient cost
Tysabri 300mg/15ml concentrate for inf vials 0802040W0BBAAAA 1 £1,130

Source: NHSBSA Prescription Cost Analysis · to October 2024 OGL v3.0

Where Natalizumab is dispensed

The regions and dispensing practices with the highest Natalizumab volumes.

Regional volumes from NHSBSA Prescription Cost Analysis; practice volumes from NHS dispensing data.

In NHS hospitals

Natalizumab is also used in NHS secondary care. See the indicative hospital cost, monthly trend and the trusts using it most on the hospital medicines page.

Compare Natalizumab with

Other medicines in the same BNF section, by prescribing volume.